Former Zimmer Biomet executive Bill McCarrick has been selected as CEO of medical device company Enlighten Mobility

SOUTH BEND, In., November 2, 2020 – Following a nationwide search, Bill McCarrick has been selected as CEO of Enlighten Mobility, a medical device company focused on early intervention solutions to advance development and recovery from loss of mobility.

Respected throughout the orthopaedic medical device industry, McCarrick has held numerous executive leadership roles in global sales, strategic marketing and relationship management. Most recently, McCarrick served as academic institute director for orthopaedic global leader Zimmer Biomet, where he managed medical education and intellectual property through collaborative programs with the nation’s top university medical schools.

“Bill stood out from other candidates because his career exemplifies our mission to challenge the status quo of mobility care for improved quality of life, especially for patients that are underserved,” said Marissa Koscielski, founder of Enlighten Mobility. “With his extensive academic affiliations and unwavering commitment to research, Bill has the know-how and determination to advance meaningful work that can make a difference for all patients.

McCarrick’s priorities as CEO focus on securing product development resources and developing strategic affiliations with the nation’s top medical institutions for Enlighten Mobility emerging technologies, including the GMat Neuromotor Screening – the first automated non-invasive neuromotor screening for newborns – to be developed through an exclusive license agreement with Nationwide Children’s Hospital.

Throughout his 28-year tenure with Zimmer Biomet, McCarrick led a variety of cross-functional growth initiatives for knee, shoulder, foot and ankle replacements, as well as trauma and spine technology. McCarrick began his career with Johnson & Johnson in medical sales of operating room products for infection control. Active in his community, McCarrick serves on the board of directors for Court Appointed Special Advocates of Kosciusko County, In., and is a board member of the Optimist Club of Warsaw, In. and the Winona Lake Preservation Association. McCarrick obtained a bachelor’s of business administration degree from the Fox School of Business at Temple University.

About Enlighten Mobility

Enlighten Mobility is a medical device company dedicated to empowering individuals with early intervention solutions to advance development and recovery from loss of mobility due to illness, injury, amputation and stroke. The company leads with clinical research, working alongside patients, caregivers and clinicians to drive innovation for diagnostic devices and rehabilitation technologies that optimize mobility care pathways. Enlighten Mobility holds an exclusive license agreement with Nationwide Children’s Hospital for the first automated non-invasive neuromotor screening, the GMat, currently in studies with the Early Detection and Intervention network of top U.S. neonatal intensive care units. Studies for the company’s patented independent walking device for lower limb amputees, the Enlight Gait Trainer, continue with The Ohio State University Wexner Medical Center. The GMat and Enlight Gait Trainer lead a robust product pipeline that includes neuromodulation integration for stroke and neurological recovery, diagnostic and therapeutic motion analysis, biofeedback augmented reality and at-home endurance training to support telehealth. South Bend, In.-based Enlighten Mobility was founded in 2017 by Marissa Koscielski after she experienced firsthand the lack of effective solutions for her own recovery from temporary unilateral immobility and set out to challenge the status quo of mobility care, which remains the company’s mission today. For more information, visit EnlightenMobility.com.

Enlighten Mobility Communications Contact:
Cathy DeRonne
media@enlightenmobility.com